window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 19, 2026

  • News
  • About Us
Contact Us

Gene Editing

  • Biotech,Cell & Gene Therapy,Partnerships & Funding,Research & Development

    MaxCyte signs platform licence with Moonlight Bio to advance T cell therapies for solid tumours

    MaxCyte has entered a strategic platform licence with US biotech [...]

    October 13, 2025
  • Biotech,Genomics and sequencing,Partnerships & Funding,Rare Diseases,Research & Development

    Chiesi and Arbor partner on rare disease gene editing programmes targeting PH1 and other liver disorders

    Chiesi Group has entered into an exclusive global partnership with [...]

    October 7, 2025
  • Cell & Gene Therapy,Clinical Development,Clinical Trials,European biotech,Partnerships & Funding,Patient Centricity

    Anocca raises SEK 440M to advance TCR-T cell therapies into clinical development

    Swedish clinical-stage biotech Anocca AB has secured approximately SEK 440 [...]

    August 19, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy,Oncology

    Broken String renews NIST gene editing safety push with INDUCE-seq technology

    Broken String Biosciences has reaffirmed its commitment to supporting the [...]

    August 5, 2025
  • Cell & Gene Therapy,Partnerships & Funding,Technology and platforms

    Broken String and BioLizard partner on AI tool to improve gene editing safety

    Eurostars-3 grant supports development of SafeGuide to reduce time and [...]

    July 14, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy

    MaxCyte and Ori Biotech integrate platforms to improve cell therapy manufacturing

    CD19 CAR CRISPR T cell workflow used to demonstrate shortened [...]

    June 12, 2025
  • Cell & Gene Therapy

    Cellistic unveils Echo-NK platform to scale up iPSC-based cell therapies

    April 22, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth
    Categories: Biotech, Clinical Development, Clinical studies, Clinical Trials, Healthcare leadership, Movers & Shakers, Rare Diseases
  • Will Edwards appointed CEO as Astoriom expands international storage and biorepository operations
    Categories: Biomanufacturing, CDMOs & Manufacturing, Healthcare leadership, Movers & Shakers, Pharmaceuticals and therapeutics
  • CombinAbleAI to be acquired by insitro to expand AI drug discovery platform
    Categories: Artificial Intelligence, Biotech, Drug Development, Mergers & Acquisitions, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top